x
Filter:
Filters applied
- Molecular Bases of Disease
- Hazen, Stanley LRemove Hazen, Stanley L filter
- Huang, YingRemove Huang, Ying filter
Publication Date
Please choose a date range between 2016 and 2022.
Author
- DiDonato, Joseph A3
- Gogonea, Valentin3
- Buffa, Jennifer A2
- DiDonato, Anthony J2
- Baleanu-Gogonea, Camelia1
- Battle, Shawna1
- Cameron, Scott J1
- Choucair, Ibrahim1
- Crabb, John W1
- Ellington, Andrew D1
- Fox, Paul L1
- Fu, Xiaoming1
- Graham, Linda M1
- Gu, Xiaodong1
- Hazen, Leah B1
- Hughes, Randall A1
- Levison, Bruce S1
- Li, Xinmin S1
- Mehl, Ryan A1
- Parks, John S1
- Wagner, Matthew A1
- Wang, Zeneng1
- Willard, Belinda1
Molecular Bases of Disease
3 Results
- Research ArticleOpen Access
The pattern of apolipoprotein A-I lysine carbamylation reflects its lipidation state and the chemical environment within human atherosclerotic aorta
Journal of Biological ChemistryVol. 298Issue 4101832Published online: March 15, 2022- Shawna Battle
- Valentin Gogonea
- Belinda Willard
- Zeneng Wang
- Xiaoming Fu
- Ying Huang
- and others
Cited in Scopus: 2Protein lysine carbamylation is an irreversible post-translational modification resulting in generation of homocitrulline (N-ε-carbamyllysine), which no longer possesses a charged ε-amino moiety. Two distinct pathways can promote protein carbamylation. One results from urea decomposition, forming an equilibrium mixture of cyanate (CNO−) and the reactive electrophile isocyanate. The second pathway involves myeloperoxidase (MPO)-catalyzed oxidation of thiocyanate (SCN−), yielding CNO− and isocyanate. - Molecular Bases of DiseaseOpen Access
Site-specific 5-hydroxytryptophan incorporation into apolipoprotein A-I impairs cholesterol efflux activity and high-density lipoprotein biogenesis
Journal of Biological ChemistryVol. 295Issue 15p4836–4848Published online: February 25, 2020- Maryam Zamanian-Daryoush
- Valentin Gogonea
- Anthony J. DiDonato
- Jennifer A. Buffa
- Ibrahim Choucair
- Bruce S. Levison
- and others
Cited in Scopus: 13Apolipoprotein A-I (apoA-I) is the major protein constituent of high-density lipoprotein (HDL) and a target of myeloperoxidase-dependent oxidation in the artery wall. In atherosclerotic lesions, apoA-I exhibits marked oxidative modifications at multiple sites, including Trp72. Site-specific mutagenesis studies have suggested, but have not conclusively shown, that oxidative modification of Trp72 of apoA-I impairs many atheroprotective properties of this lipoprotein. Herein, we used genetic code expansion technology with an engineered Saccharomyces cerevisiae tryptophanyl tRNA-synthetase (Trp-RS):suppressor tRNA pair to insert the noncanonical amino acid 5-hydroxytryptophan (5-OHTrp) at position 72 in recombinant human apoA-I and confirmed site-specific incorporation utilizing MS. - Protein Structure and FoldingOpen Access
A Systematic Investigation of Structure/Function Requirements for the Apolipoprotein A-I/Lecithin Cholesterol Acyltransferase Interaction Loop of High-density Lipoprotein
Journal of Biological ChemistryVol. 291Issue 12p6386–6395Published online: January 21, 2016- Xiaodong Gu
- Zhiping Wu
- Ying Huang
- Matthew A. Wagner
- Camelia Baleanu-Gogonea
- Ryan A. Mehl
- and others
Cited in Scopus: 14The interaction of lecithin-cholesterol acyltransferase (LCAT) with apolipoprotein A-I (apoA-I) plays a critical role in high-density lipoprotein (HDL) maturation. We previously identified a highly solvent-exposed apoA-I loop domain (Leu159–Leu170) in nascent HDL, the so-called “solar flare” (SF) region, and proposed that it serves as an LCAT docking site (Wu, Z., Wagner, M. A., Zheng, L., Parks, J. S., Shy, J. M., 3rd, Smith, J. D., Gogonea, V., and Hazen, S. L. (2007) Nat. Struct. Mol. Biol. 14, 861–868).